BOSTON ( TheStreet) -- PetroChina ( PTR), Corning ( GLW) and Tenet Healthcare ( THC) had their stock ratings upgraded by TheStreet's quantitative model.
3.Tenet Healthcare was raised to "hold." Quarter: Tenet swung to a fourth-quarter profit of $27 million, or 3 cents a share, from a loss of $33 million, or 1 cent, a year earlier. Revenue ascended 3.9% to $2.3 billion. The operating margin rose to 5.4%. Tenet has $703 million of cash and $4.3 billion of debt. Stock: Tenet has quintupled in the past year, outperforming U.S. indices. The stock trades at a price-to-sales ratio of 0.3 and a price-to-cash-flow ratio of 6.6, 60% and 33% discounts to industry averages. It's expensive based on book value. Consensus: Of analysts covering Tenet, nine recommend purchasing its shares, 10 advise holding and one suggests selling them. Deutsche Bank ( DB), which rates Tenet "buy," expects the stock to advance 62% to $9.50. Avondale expects the shares to hit $9. 2.PetroChina was lifted to "buy." Quarter: Fourth-quarter profit gained 15% to $3.2 billion, or $1.77, as revenue soared 59% to $49 billion. The operating margin widened from 10% to 11%. PetroChina has $13 billion of cash and $34 billion of debt, translating to a debt-to-equity ratio of 0.3. Stock: PetroChina has gained 35% in the past 12 months, trailing major benchmarks. The stock sells for a price-to-projected-earnings ratio of 9.6 and a price-to-cash-flow ratio of 5.4, 29% and 40% discounts to industry averages. It's also cheap based on sales. Consensus: Of researchers evaluating PetroChina, two rate its stock "buy," one rates it "hold" and one ranks it "sell." Sanford Bernstein projects a share price of $161, leaving a potential 40% gain. Goldman Sachs ( GS) is neutral on the stock.